Cargando…

Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mice

Infection by Mycobacterium tuberculosis (Mtb) remains a major global concern and the available Bacillus Calmette-Guerin (BCG) vaccine is poorly efficacious in adults. Therefore, alternative vaccines and delivery strategies focusing on Mtb antigens and appropriate immune stimulating adjuvants are nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Arshad, Singh, Shailbala, Galvan, Gloria, Jagannath, Chinnaswamy, Sastry, K. Jagannadha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748613/ https://www.ncbi.nlm.nih.gov/pubmed/29210987 http://dx.doi.org/10.3390/vaccines5040047

Ejemplares similares

Sublingual Vaccination Induces Mucosal and Systemic Adaptive Immunity for Protection against Lung Tumor Challenge
por: Singh, Shailbala, et al.
Publicado: (2014)

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014)

Natural Killer Dendritic Cells Enhance Immune Responses Elicited by α-Galactosylceramide-Stimulated Natural Killer T Cells
por: Lee, Sung Won, et al.
Publicado: (2013)

Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines
por: Gonzalez-Aseguinolaza, Gloria, et al.
Publicado: (2002)

Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide
por: Croudace, Joanne E, et al.
Publicado: (2008)

Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
por: Davitt, Christopher J. H., et al.
Publicado: (2019)

Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8(+) T Lymphocytes in the Female Reproductive Tract
por: Singh, Shailbala, et al.
Publicado: (2016)

α‐galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice
por: Chen, Qianhui, et al.
Publicado: (2018)

Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
por: Zhang, Lianjun, et al.
Publicado: (2017)

Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza
por: Barthelemy, Adeline, et al.
Publicado: (2016)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Sublingual nucleotides and immune response to exercise
por: Ostojic, Sergej M, et al.
Publicado: (2012)

Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor
por: Osada, Takuya, et al.
Publicado: (2004)

Natural Killer T Cell Ligand α‐Galactosylceramide Inhibited Lymph Node Metastasis of Highly Metastatic Melanoma Cells
por: Nakui, Minoru, et al.
Publicado: (1999)

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15
por: Hsu, Chien-Ya, et al.
Publicado: (2021)

Editorial: The Autophagy Pathway: Bacterial Pathogen Immunity and Evasion
por: Jagannath, Chinnaswamy, et al.
Publicado: (2021)

Pulmonary and extra-pulmonary manifestations of sarcoidosis
por: Tavana, Sasan, et al.
Publicado: (2015)

A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
por: Khan, Arshad, et al.
Publicado: (2021)

CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
por: Brossay, Laurent, et al.
Publicado: (1998)

Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
por: Bahceciler, Nerin N.
Publicado: (2012)

Sublingual Delivery of Vaccines for the Induction of Mucosal Immunity
por: Shim, Byoung-Shik, et al.
Publicado: (2013)

Radiation recall pneumonitis from immune checkpoint inhibitors after extra pulmonary radiation
por: Kao, Leslie E., et al.
Publicado: (2023)

COVID-19: Pulmonary and Extra Pulmonary Manifestations
por: Elrobaa, Islam H., et al.
Publicado: (2021)

Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)

Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-Galactosylceramide
por: Schmieg, John, et al.
Publicado: (2003)

α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans
por: Abe, Masahiro, et al.
Publicado: (2021)

Allied health – 3007. The biomarker of sublingual immune therapy
por: Sakashita, Masafumi, et al.
Publicado: (2013)

Predictors of pulmonary involvement in patients with extra-pulmonary tuberculosis
por: El-Hazmi, Malak M., et al.
Publicado: (2012)

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
por: Johnson, Kemmian D., et al.
Publicado: (2020)

NKT Cell Stimulation with α-Galactosylceramide Results in a Block of Th17 Differentiation after Intranasal Immunization in Mice
por: Zygmunt, Beata M., et al.
Publicado: (2012)

Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy
por: Singh, M, et al.
Publicado: (2014)

GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?
por: Mishra, Abhishek, et al.
Publicado: (2020)

Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
por: Fujii, Shin-ichiro, et al.
Publicado: (2003)

Development of Mucosal Immunity in Children: A Rationale for Sublingual Immunotherapy?
por: Szczawinska-Poplonyk, Aleksandra
Publicado: (2012)

489 Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism?
por: Sensi, Laura Giovanna, et al.
Publicado: (2012)

The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines
por: Liu, Yonghui, et al.
Publicado: (2021)

Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
por: Wang, Ying, et al.
Publicado: (2020)

Glucosylceramide and galactosylceramide, small glycosphingolipids with significant impact on health and disease
por: Reza, Safoura, et al.
Publicado: (2021)

Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza
por: Shim, Byoung-Shik, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s2ug760em39vfibpfljllcam83